XML 37 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue $ 18,273,442 $ 22,526,201
Cost of Goods Sold 16,697,296 20,379,519
Gross Profit 1,576,146 2,146,682
Operating Expenses:    
Selling expenses 4,564,188 2,918,418
General and administrative expenses 5,836,629 6,205,040
Research and development expenses 1,862,653 1,278,331
Total Operating Expenses 12,263,470 10,401,789
Loss from Operations (10,687,324) (8,255,107)
Other Income (Expense)    
Gain on modification of earn-out liability 0 306,077
Interest and other income 371,467 139,513
Interest expense (708,176) (120,903)
Amortization of discount on convertible note (835,331) 0
Fair value adjustment of warrants 0 (901,250)
Gain (Loss) on currency transactions 668,225 (1,469,607)
Gain (Loss) on sale of fixed assets 1,113 27,772
Total Other Income (Expense) (502,672) (2,018,398)
Loss Before Income Taxes (11,189,996) (10,273,505)
Income Tax Benefit (63,036) (465,145)
Net Loss $ (11,126,960) $ (9,808,360)
Basic and Diluted Loss Per Share (in dollars per share) $ (0.52) $ (0.46)
Basic and Diluted Weighted Average Common Shares Outstanding (in shares) 21,567,112 21,209,118